Product category:
Nucleic acid sequencing and synthesis
News Release from: Applied Biosystems
Edited by the Laboratorytalk Editorial
Team on 23 March 2007
Software initiative targets drug
discovery
The new software developments will improve the speed and accuracy of Adme testing of drug candidates, helping to lower the costly drug failure rate during pre-clinical stages of the development cycle
Applied Biosystems and its joint venture partner MDS Sciex have created a new software development initiative to help pharmaceutical companies determine drug candidate viability early in the development pipeline through better analysis of the absorption, distribution, metabolism and excretion (Adme) properties of compounds The new software developments will improve the speed and accuracy of Adme testing of drug candidates, helping to lower the costly drug failure rate during pre-clinical stages of the development cycle
This article was originally published on Laboratorytalk on 2 Oct 2001 at 8.00am (UK)
Related stories
High throughput nucleic acid purification
Applied Biosystems has released the ABI Prism 6100 nucleic acid PrepStation for high throughput purification of RNA and DNA, taking only 30 minutes to isolate total RNA from cells
Cattle DNA typing kit
Applied BioSystems says that complete traceability from farm to supermarket is now a reality, providing a new tool to establish the safety of food products
The Applied Biosystems/MDS Sciex approach creates a more intuitive method for managing the screening of compounds by increased automation of the analytical process, particularly quantitative mass spectrometry tailored for drug discovery laboratories.
The analytical accuracy, sensitivity and quantitative capabilities of the mass spectrometry instruments and software provided by Applied Biosystems/MDS Sciex have helped to make mass spectrometry-based systems the preferred method for pharmaceutical research.
As part of the initiative, Applied Biosystems/MDS Sciex is collaborating with Sound Analytics and Pfizer to design these software applications.
Sound Analytics - a scientific applications company that has been working on automation features with Pfizer for six years - will provide expertise in early Adme software development while Pfizer, the world's largest research-based pharmaceutical company, will provide the guidance to shape the requirements for the new Adme software applications.
• Applied Biosystems: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
